GSA Capital Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Sell |
137,951
-44,399
| -24% | -$490K | 0.11% | 230 |
|
|
2025
Q1 | $1.63M | Buy |
182,350
+19,363
| +12% | +$173K | 0.15% | 136 |
|
|
2024
Q4 | $1.53M | Sell |
162,987
-66,793
| -29% | -$629K | 0.11% | 183 |
|
|
2024
Q3 | $1.85M | Buy |
229,780
+25,691
| +13% | +$207K | 0.14% | 151 |
|
|
2024
Q2 | $1.73M | Buy |
+204,089
| New | +$1.73M | 0.12% | 207 |
|
|
2024
Q1 | – | Sell |
-77,070
| Closed | -$866K | – | 1959 |
|
|
2023
Q4 | $866K | Sell |
77,070
-248,915
| -76% | -$2.8M | 0.07% | 464 |
|
|
2023
Q3 | $2.81M | Buy |
325,985
+306,064
| +1,536% | +$2.64M | 0.24% | 41 |
|
|
2023
Q2 | $206K | Sell |
19,921
-85,342
| -81% | -$883K | 0.02% | 1253 |
|
|
2023
Q1 | $1.14M | Buy |
105,263
+47,686
| +83% | +$517K | 0.11% | 252 |
|
|
2022
Q4 | $646K | Buy |
+57,577
| New | +$646K | 0.08% | 440 |
|
|
2022
Q3 | – | Sell |
-114,646
| Closed | -$1.04M | – | 1850 |
|
|
2022
Q2 | $1.04M | Buy |
114,646
+65,190
| +132% | +$591K | 0.16% | 133 |
|
|
2022
Q1 | $473K | Buy |
+49,456
| New | +$473K | 0.06% | 569 |
|
|
2020
Q4 | – | Sell |
-13,965
| Closed | -$206K | – | 1584 |
|
|
2020
Q3 | $206K | Buy |
+13,965
| New | +$206K | 0.03% | 992 |
|
|
2019
Q4 | – | Sell |
-10,745
| Closed | -$209K | – | 1718 |
|
|
2019
Q3 | $209K | Buy |
+10,745
| New | +$209K | 0.03% | 1152 |
|